Clinical Trial Update: Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tirilizumab in combination with albumin-bound paclitaxel and cisplatin for locally advanced resectable oral squamous cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oral Squamous Cell Carcinoma

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• CISPLATIN (cisplatin)
• Tirilizumab

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING